Literature DB >> 20851878

Transcriptional repressor E4-binding protein 4 (E4BP4) regulates metabolic hormone fibroblast growth factor 21 (FGF21) during circadian cycles and feeding.

Xin Tong1, Marina Muchnik, Zheng Chen, Manish Patel, Nan Wu, Shree Joshi, Liangyou Rui, Mitchell A Lazar, Lei Yin.   

Abstract

Fibroblast growth factor 21 (FGF21) is a potent antidiabetic and triglyceride-lowering hormone whose hepatic expression is highly responsive to food intake. FGF21 induction in the adaptive response to fasting has been well studied, but the molecular mechanism responsible for feeding-induced repression remains unknown. In this study, we demonstrate a novel link between FGF21 and a key circadian output protein, E4BP4. Expression of Fgf21 displays a circadian rhythm, which peaks during the fasting phase and is anti-phase to E4bp4, which is elevated during feeding periods. E4BP4 strongly suppresses Fgf21 transcription by binding to a D-box element in the distal promoter region. Depletion of E4BP4 in synchronized Hepa1c1c-7 liver cells augments the amplitude of Fgf21 expression, and overexpression of E4BP4 represses FGF21 secretion from primary mouse hepatocytes. Mimicking feeding effects, insulin significantly increases E4BP4 expression and binding to the Fgf21 promoter through AKT activation. Thus, E4BP4 is a novel insulin-responsive repressor of FGF21 expression during circadian cycles and feeding.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20851878      PMCID: PMC2978569          DOI: 10.1074/jbc.M110.172866

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

1.  Regulation of FGF21 expression and secretion by retinoic acid receptor-related orphan receptor alpha.

Authors:  Yongjun Wang; Laura A Solt; Thomas P Burris
Journal:  J Biol Chem       Date:  2010-03-23       Impact factor: 5.157

Review 2.  The role of clock genes in pharmacology.

Authors:  Georgios K Paschos; Julie E Baggs; John B Hogenesch; Garret A FitzGerald
Journal:  Annu Rev Pharmacol Toxicol       Date:  2010       Impact factor: 13.820

3.  Abnormal expressions of circadian-clock and circadian clock-controlled genes in the livers and kidneys of long-term, high-fat-diet-treated mice.

Authors:  M-C Hsieh; S-C Yang; H-L Tseng; L-L Hwang; C-T Chen; K-R Shieh
Journal:  Int J Obes (Lond)       Date:  2009-11-10       Impact factor: 5.095

Review 4.  The mammalian circadian timing system: organization and coordination of central and peripheral clocks.

Authors:  Charna Dibner; Ueli Schibler; Urs Albrecht
Journal:  Annu Rev Physiol       Date:  2010       Impact factor: 19.318

5.  Thyroid hormone regulates hepatic expression of fibroblast growth factor 21 in a PPARalpha-dependent manner.

Authors:  Andrew C Adams; Inna Astapova; Ffolliott M Fisher; Michael K Badman; Katherine E Kurgansky; Jeffrey S Flier; Anthony N Hollenberg; Eleftheria Maratos-Flier
Journal:  J Biol Chem       Date:  2010-03-17       Impact factor: 5.157

6.  PGC-1alpha negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erb(alpha) axis.

Authors:  Jennifer L Estall; Jorge L Ruas; Cheol Soo Choi; Dina Laznik; Michael Badman; Eleftheria Maratos-Flier; Gerald I Shulman; Bruce M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

7.  IL-4-induced transcription factor NFIL3/E4BP4 controls IgE class switching.

Authors:  Masaki Kashiwada; Deborah M Levy; Lisa McKeag; Keri Murray; Andreas J Schröder; Stephen M Canfield; Geri Traver; Paul B Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

8.  A promoter in the novel exon of hPPARgamma directs the circadian expression of PPARgamma.

Authors:  Seiichiro Takahashi; Ikuo Inoue; Yoshihiro Nakajima; Makoto Seo; Takanari Nakano; Fang Yang; Megumi Kumagai; Tsugikazu Komoda; Takuya Awata; Masaaki Ikeda; Shigehiro Katayama
Journal:  J Atheroscler Thromb       Date:  2010-01-21       Impact factor: 4.928

9.  Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine.

Authors:  Ann M Thomas; Steven N Hart; Bo Kong; Jianwen Fang; Xiao-Bo Zhong; Grace L Guo
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

10.  Five-vertebrate ChIP-seq reveals the evolutionary dynamics of transcription factor binding.

Authors:  Dominic Schmidt; Michael D Wilson; Benoit Ballester; Petra C Schwalie; Gordon D Brown; Aileen Marshall; Claudia Kutter; Stephen Watt; Celia P Martinez-Jimenez; Sarah Mackay; Iannis Talianidis; Paul Flicek; Duncan T Odom
Journal:  Science       Date:  2010-04-08       Impact factor: 47.728

View more
  50 in total

Review 1.  Transcriptional regulation of innate lymphoid cell fate.

Authors:  Nicolas Serafini; Christian A J Vosshenrich; James P Di Santo
Journal:  Nat Rev Immunol       Date:  2015-06-12       Impact factor: 53.106

Review 2.  Circadian clocks regulate cardiac arrhythmia susceptibility, repolarization, and ion channels.

Authors:  Brian P Delisle; John L Stumpf; Jennifer L Wayland; Sidney R Johnson; Makoto Ono; Dalton Hall; Don E Burgess; Elizabeth A Schroder
Journal:  Curr Opin Pharmacol       Date:  2020-11-09       Impact factor: 5.547

Review 3.  Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease.

Authors:  Michelle T Long; Sanil Gandhi; Rohit Loomba
Journal:  Metabolism       Date:  2020-05-05       Impact factor: 8.694

4.  Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands.

Authors:  Regina Goetz; Mutsuko Ohnishi; Xunshan Ding; Hiroshi Kurosu; Lei Wang; Junko Akiyoshi; Jinghong Ma; Weiming Gai; Yisrael Sidis; Nelly Pitteloud; Makoto Kuro-O; Mohammed S Razzaque; Moosa Mohammadi
Journal:  Mol Cell Biol       Date:  2012-03-26       Impact factor: 4.272

Review 5.  Fibroblast growth factor 21: a regulator of metabolic disease and health span.

Authors:  Ting Xie; Po Sing Leung
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-05-30       Impact factor: 4.310

6.  Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes.

Authors:  Wei Chen; Ruby Lai-chong Hoo; Morichika Konishi; Nobuyuki Itoh; Pui-Chi Lee; Hong-ying Ye; Karen Siu-ling Lam; Aimin Xu
Journal:  J Biol Chem       Date:  2011-08-17       Impact factor: 5.157

7.  Glucocorticoids regulate the metabolic hormone FGF21 in a feed-forward loop.

Authors:  Rucha Patel; Angie L Bookout; Lilia Magomedova; Bryn M Owen; Giulia P Consiglio; Makoto Shimizu; Yuan Zhang; David J Mangelsdorf; Steven A Kliewer; Carolyn L Cummins
Journal:  Mol Endocrinol       Date:  2014-12-11

8.  Recruitment of histone methyltransferase G9a mediates transcriptional repression of Fgf21 gene by E4BP4 protein.

Authors:  Xin Tong; Deqiang Zhang; Katie Buelow; Anirvan Guha; Blake Arthurs; Hugh J M Brady; Lei Yin
Journal:  J Biol Chem       Date:  2013-01-02       Impact factor: 5.157

9.  Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21.

Authors:  Marion Cornu; Wolfgang Oppliger; Verena Albert; Aaron M Robitaille; Francesca Trapani; Luca Quagliata; Tobias Fuhrer; Uwe Sauer; Luigi Terracciano; Michael N Hall
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-31       Impact factor: 11.205

10.  The cardiomyocyte molecular clock, regulation of Scn5a, and arrhythmia susceptibility.

Authors:  Elizabeth A Schroder; Mellani Lefta; Xiping Zhang; Daniel C Bartos; Han-Zhong Feng; Yihua Zhao; Abhijit Patwardhan; Jian-Ping Jin; Karyn A Esser; Brian P Delisle
Journal:  Am J Physiol Cell Physiol       Date:  2013-01-30       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.